Revance Therapeutics
RVNC
$3.32
Share price
-22.61%
Change (1 day)
-90.56%
Change (1 year)
Categories
Number of shares outstanding for Revance Therapeutics (RVNC)
Number of shares outstanding as of May 2024 : 86,613,425
According to Revance Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 86,613,425. At the end of 2023 the company had 86,613,425 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Revance Therapeutics from 2013 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 86.61 M | 8.1% |
| 2022 | 80.12 M | 17.77% |
| 2021 | 68.03 M | 7.48% |
| 2020 | 63.29 M | 38.73% |
| 2019 | 45.62 M | 25.57% |
| 2018 | 36.33 M | 15.05% |
| 2017 | 31.58 M | 11.98% |
| 2016 | 28.2 M | 6.58% |
| 2015 | 26.46 M | 12.64% |
| 2014 | 23.49 M | 32.39% |
| 2013 | 17.74 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,408,200,000 | 2,680.40% | 🇺🇸 USA |
 Biogen BIIB | 145,200,000 | 67.64% | 🇺🇸 USA |
 MediciNova MNOV | 49,046,246 | -43.37% | 🇺🇸 USA |